New developments in the pathology of malignant lymphoma. A review of the literature published from September–August 2017

New developments in the pathology of malignant lymphoma. A review of the literature published... Journal of Hematopathology (2017) 10:117–127 https://doi.org/10.1007/s12308-017-0310-2 REVIEW OF THE LITERATURE New developments in the pathology of malignant lymphoma. A review of the literature published from September–August 2017 J. H. van Krieken Published online: 29 November 2017 The Author(s) 2017. This article is an open access publication Introduction swath of EBER+ neoplastic cells accompanied by a rela- tive absence of reactive T cells. In all 3 cases, the cells in As I wrote in the editorial in this issue [1], it is rare to see EBER+ areas expressed latent membrane protein-1 and single-authored original articles in the medical literature, were strongly positive for CD30. Miller concluded that but in this review, there is an exception. I.J. Miller re- these three cases suggest that in a subset of EBV+ trieved 46 cases of Epstein Bar virus (EBV) positive lym- DLBCLs, EBV infection may not be the “first hit.” Anice phomas from the archives of his laboratory and looked piece of work, which indeed can be done by a single carefully at the distribution of EBV early RNA (EBER)- person. Nevertheless, it is my experience that discussion positive cells [2]. I imagine that he or she was reviewing a on data improve http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Hematopathology Springer Journals

New developments in the pathology of malignant lymphoma. A review of the literature published from September–August 2017

Loading next page...
 
/lp/springer_journal/new-developments-in-the-pathology-of-malignant-lymphoma-a-review-of-jqWAcpT4x0
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Pathology; Hematology
ISSN
1868-9256
eISSN
1865-5785
D.O.I.
10.1007/s12308-017-0310-2
Publisher site
See Article on Publisher Site

Abstract

Journal of Hematopathology (2017) 10:117–127 https://doi.org/10.1007/s12308-017-0310-2 REVIEW OF THE LITERATURE New developments in the pathology of malignant lymphoma. A review of the literature published from September–August 2017 J. H. van Krieken Published online: 29 November 2017 The Author(s) 2017. This article is an open access publication Introduction swath of EBER+ neoplastic cells accompanied by a rela- tive absence of reactive T cells. In all 3 cases, the cells in As I wrote in the editorial in this issue [1], it is rare to see EBER+ areas expressed latent membrane protein-1 and single-authored original articles in the medical literature, were strongly positive for CD30. Miller concluded that but in this review, there is an exception. I.J. Miller re- these three cases suggest that in a subset of EBV+ trieved 46 cases of Epstein Bar virus (EBV) positive lym- DLBCLs, EBV infection may not be the “first hit.” Anice phomas from the archives of his laboratory and looked piece of work, which indeed can be done by a single carefully at the distribution of EBV early RNA (EBER)- person. Nevertheless, it is my experience that discussion positive cells [2]. I imagine that he or she was reviewing a on data improve

Journal

Journal of HematopathologySpringer Journals

Published: Nov 29, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off